Maruto Sangyo Co., Ltd. Revises Earnings Forecast — Net Profit Up 80.3%
Maruto Sangyo Co., Ltd. (TSE:78940) has revised its earnings forecast for the period ending February 28, 2026, citing the recognition of special gains from the sale of shares in a subsidiary.
| Item | Before | After | Change |
|---|---|---|---|
| Revenue | JPY 18.8bn | JPY 18.775bn | -JPY 25mn (-0.1%) |
| Operating Profit | JPY 415mn | JPY 420mn | +JPY 5mn (+1.2%) |
| Ordinary Income | JPY 465mn | JPY 524mn | +JPY 59mn (+12.7%) |
| Net Profit | JPY 355mn | JPY 640mn | +JPY 285mn (+80.3%) |
| EPS | JPY 223.66 per share | JPY 403.78 per share | +JPY 180.12 per share |
The revision follows the completion of a share sale in a subsidiary (Hisamitsu Pharmaceutical tender offer), which resulted in special gains recognized in the fourth quarter, leading to higher-than-expected net profit.
The upward revision reflects the impact of the special gains, which significantly boosted net profit. Investors should monitor how this one-time benefit affects the company’s long-term performance.
Source: Original filing (TDnet) | 日本語版
This article is for informational purposes only and does not constitute investment advice. Always verify against the original filing.